Dr. Allan Halpern of Memorial Sloan Kettering Cancer Center discusses VECTRA® WB360 technology on CBS News
CBS News interviewed Dr. Allan Halpern, Chief of Dermatology at Memorial Sloan Kettering Cancer Center, about the VECTRA WB360’s advanced imaging technology. Dr. Halpern demonstrated how the system captures cross-polarized and non-polarized images using 92 cameras firing simultaneously, providing an accurate 3D representation of the patient’s skin. The VECTRA WB360 provides clinicians like Dr. Halpern a powerful tool to screen patients thoroughly, especially important now since so many have missed their normal appointments in the past year due to the pandemic. The Journal of American Academy of Dermatology reported as many as 19,600 melanomas may not have been diagnosed or treated in 2020.
Recent News in In The Media
- Advancing Skin Screenings: Dr. Charles E. Mount III and Director Howard Edington, MD Discuss VECTRA® WB360 at AHN Cancer Institute with CBS News
- Dr. Robyn Siperstein, M.D., discusses Canfield’s revolutionary AI & AR technology and its role in consultations in MedEsthetics Magazine
- Canfield’s VECTRA® WB360 recently installed at Allegheny Health Network Cancer Institute
- Dr. Sherina Balaratnam discusses with Francesca Ogiermann-White why Canfield’s VISIA® is an essential part of all her consultations
Most Recent News
- Advancing Skin Screenings: Dr. Charles E. Mount III and Director Howard Edington, MD Discuss VECTRA® WB360 at AHN Cancer Institute with CBS News
- National Doctors’ Day, Spotlighting Glynis Ablon, MD, FAAD
- Dr. Robyn Siperstein, M.D., discusses Canfield’s revolutionary AI & AR technology and its role in consultations in MedEsthetics Magazine
- VISIA®’s 5th Consecutive Win as Favorite Diagnostic Tool in Dermascope’s Aestheticians’ Choice Awards!